Page 109 - Cardiac abnormalities after aneurysmal subarachnoid hemorrhage

General Discussion
47. Oppenheimer SM, Gelb A, Girvin JP, Hachinski VC. Cardiovascular Effects of Human Insular Cortex
Stimulation. Neurology 1992;42:1727-1732.
48. Elrifai AM, Dureza C BJ. Cardiac and Systemic Medical Complications of Subarachnoid Hemorrhage. Subarachnoid Hemorrhage: Pathophysiology and Management.Illinois: The American Association of Neurological Surgeons; 1997. p. 87-116.
49. Ulphani JS, Cain JH, Inderyas F, Gordon D, Gikas PV, Shade G, Mayor D, Arora R, Kadish AH, Goldberger JJ. Quantitative analysis of parasympathetic innervation of the porcine heart. Heart Rhythm 2010 August;7(8):1113-1119.
50. naredi S., Lambert G, Eden E, Zall S., Runnerstam M., Rydenhag B., Friberg P. Increased sympathetic nervous activity in patients with nontraumatic subarachnoid hemorrhage. Stroke 2000;31(901):906.
51. Rona G. Catecholamine cardiotoxicity. J Mol Cell Cardiol 1985;17(4):291-306.
52. Zaroff JG, Rordorf GA, Titus JS, Newell JB, Nowak NJ, Torchiana DF, Aretz HT, Picard MH, Macdonald RL. Regional myocardial perfusion after experimental subarachnoid hemorrhage. Stroke 2000 May;31(5):1136-1143.
53. Rosenbaum J, Billingham M.E., Ginsburg R, Tsujimoto G., Lurie K.G., Hoffman BB. Cardiomyopathy in a rat model of pheochromocytoma. Morphological and functional alterations. Am J Cardiovasc Pathol 1988;1(3):389-399.
54. Prichard BN, Owens CW, Smith CC, Walden RJ. Heart and catecholamines. Acta Cardiol 1991;46(3):309- 322.
55. Novitzky D, wicomb W.N., Cooper DK, Rose AG, Reichart B. Prevention of myocardial injury during brain death by total cardiac sympathectomy in the Chacma baboon. Ann Thorac Surg 1986;41(5):520- 524.
56. Burnstock G, Campbell G, Bennett M, Holman ME. Inhibition of the smooth mucle cell on the taenia coli. Nature 1963 November 9;200:581-582.
57. Su C, Bevan JA, Burnstock G. [3H]adenosine triphosphate: release during stimulation of enteric nerves. Science 1971 July 23;173(3994):336-338.
58. Abbracchio MP, Burnstock G, Verkhratsky A, Zimmermann H. Purinergic signalling in the nervous system: an overview. Trends Neurosci 2009 January;32(1):19-29.
59. Yetgin T, Uitterdijk A, Te Lintel HM, Merkus D, Krabbendam-Peters I, van Beusekom HM, Falotico R, Serruys PW, Manintveld OC, van Geuns RJ, Zijlstra F, Duncker DJ. Limitation of Infarct Size and No- Reflow by Intracoronary Adenosine Depends Critically on Dose and Duration. JACC Cardiovasc Interv 2015 December 28;8(15):1990-1999.
60. Sato T, Sasaki N, O’Rourke B, Marban E. Adenosine primes the opening of mitochondrial ATP-sensitive potassium channels: a key step in ischemic preconditioning? Circulation 2000 August 15;102(7):800-805.
61. Brennan S, Jackson R, Patel M, Sims MW, Hudman D, Norman RI, Lodwick D, Rainbow RD. Early opening of sarcolemmal ATP-sensitive potassium channels is not a key step in PKC-mediated cardioprotection. J Mol Cell Cardiol 2015 February;79:42-53.
62. Siwadlowski W., Aravanis C., Worthen M., Luisada A.A. Mechanism of adrenalin pulmonary edema and its prevention by narcotics and autonomic blockers. Chest 1970;57:554-557.
63. Neil-Dwyer G, Walter P, Cruickshank J, Doshi B., O’Gorman P. Effect of propranolol and phentolamine on myocardial necrosis after subarachnoid haemorrhage. Br Med J 1978;2(6143):990-992.
64. Parr MJ, Finfer SR, Morgan MK. Reversible cardiogenic shock complicating subarachnoid haemorrhage. 7 Br Med J 1996;313:681-683.
65. Schell AR, Shenoy MM, Friedman SA, Patel AR. Pulmonary edema associated with subarachnoid hemorrhage. Evidence for a cardiogenic origin. Arch Intern Med 1987;147:591-592.
107